The use of ampligen alone and in combination with ganciclovir and coumermycin A1 for the treatment of ducks congenitally-infected with duck hepatitis B virus
- 1 June 1993
- journal article
- Published by Elsevier in Antiviral Research
- Vol. 21 (2) , 155-171
- https://doi.org/10.1016/0166-3542(93)90051-j
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Antiviral strategies in chronic hepatitis B virus infection: II. Inhibition of duck hepatitis B Virus in vitro using conventional antiviral agents and supercoiled‐DNA active compoundsJournal of Medical Virology, 1990
- Antiviral strategies in chronic hepatitis B virus infection: I. Establishment of an in vitro system using the duck hepatitis B virus modelJournal of Medical Virology, 1990
- Reduced duck hepatitis B virus viraemia in ducklings coinfected with the immunodepressive reticuloendotheliosis virusJournal of Medical Virology, 1990
- Preliminary evidence that azidothymidine does not affect hepatitis B virus replication in acquired immunodeficiency syndrome (AIDS) patientsJournal of Medical Virology, 1989
- LOSS OF HBsAg WITH INTERFERON THERAPY IN CHRONIC HEPATITIS B VIRUS INFECTIONThe Lancet, 1987
- CLINICAL, IMMUNOLOGICAL, AND VIROLOGICAL EFFECTS OF AMPLIGEN, A MISMATCHED DOUBLE-STRANDED RNA, IN PATIENTS WITH AIDS OR AIDS-RELATED COMPLEXThe Lancet, 1987
- NATURAL DUCK HEPATITIS B VIRUS INFECTION IN AUSTRALIAAustralian Journal of Experimental Biology and Medical Science, 1986
- Interferon in viral hepatitis: Role in pathogenesis and treatmentHepatology, 1986
- HEPATOCELLULAR CARCINOMA AND HEPATITIS B VIRUSThe Lancet, 1981
- Structural requirements of the rIn·rCn complex for Induction of human interferonJournal of Molecular Biology, 1972